Daily as of 3 Nov 16:00 ET
- Price
- between the two $8.83 vs 50 $11.38 / 200 $5.90
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 14 Jan 2026 · projected 29 bars out · tested 6 bars
IOVA | Iovance BiotherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$8.83
+$0.81 (+10.10%)
Iovance Biotherapeutics (IOVA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat above the 200 on the daily since Jan 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $8.48 vs 50 $5.21 / 200 $6.35
- Projection
- 🟨Golden cross projected in 11 bars
- Test
- No active test
- Last cross
- 💀Death cross week of 14 Feb 2022 · projected 21 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- between the two $8.74 vs 50 $13.44 / 200 $8.22
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 15 Dec 2025 bar 1 · not projected · tested 3 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 14 Jan 2026 | 🟨Golden moderate | daily | 29 bars out | 6 bar cross test |
| 15 Dec 2025 | 🟨Golden | 4-hour | not projected | 3 bar cross test |
| 10 Oct 2025 | 💀Death | 4-hour | 27 bars out | — |
| 13 Aug 2025 | 🟨Golden | 4-hour | 24 bars out | — |
| 4 Dec 2024 | 💀Death | 4-hour | 29 bars out | — |
About IOVA
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$137M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmid